Fetal Bovine Serum Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global fetal bovine serum market looks promising with opportunities in biopharmaceutical, cell culture, and human & animal vaccine production applications. The global fetal bovine serum market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are increasing research activities related to drug discovery and rising biopharmaceutical production.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global fetal bovine serum market report, please download the report brochure.
In this market, cell culture is the largest application of fetal bovine serum, whereas biotechnology & pharmaceutical company is the largest end user. Growth in various segments of the fetal bovine serum market are given below:
The study includes trends and forecast for the global fetal bovine serum market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Charcoal Stripped
Chromatographic
Dialyzed FBS (Fetal Bovine Serum)
Exosome Depleted
Stem Cell
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biopharmaceutical
Cell Culture
Human & Animal Vaccine Production
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic Institutes
Research Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the fetal bovine serum companies profiled in this report include Merck, GE Healthcare, Thermo Fisher Scientific, TCS Biosciences, HiMedia Laboratories, Atlanta Biologicals, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals, and Tissue Culture Biologicals.
Lucintel forecasts that cell culture will remain the largest application segment over the forecast period due to its increasing usage as a supplementary substance during cell culture protocols in order to give cultured cells optimum growth factors, growing awareness of the benefits of cell culture-based vaccines, and rising focus on personalized medicine.
Within this market, biotechnology and pharmaceutical companies will remain the largest end user segment over the forecast period due to increasing research and development activities related to drug discovery and increasing production of vaccines.
North America will remain the largest region over the forecast period due to increasing research and development activities in biotechnology, rising healthcare investments by manufacturers, and presence of major players in the region.
The future of the global fetal bovine serum market looks promising with opportunities in biopharmaceutical, cell culture, and human & animal vaccine production applications. The global fetal bovine serum market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are increasing research activities related to drug discovery and rising biopharmaceutical production.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global fetal bovine serum market report, please download the report brochure.
In this market, cell culture is the largest application of fetal bovine serum, whereas biotechnology & pharmaceutical company is the largest end user. Growth in various segments of the fetal bovine serum market are given below:
The study includes trends and forecast for the global fetal bovine serum market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Charcoal Stripped
Chromatographic
Dialyzed FBS (Fetal Bovine Serum)
Exosome Depleted
Stem Cell
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biopharmaceutical
Cell Culture
Human & Animal Vaccine Production
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic Institutes
Research Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the fetal bovine serum companies profiled in this report include Merck, GE Healthcare, Thermo Fisher Scientific, TCS Biosciences, HiMedia Laboratories, Atlanta Biologicals, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals, and Tissue Culture Biologicals.
Lucintel forecasts that cell culture will remain the largest application segment over the forecast period due to its increasing usage as a supplementary substance during cell culture protocols in order to give cultured cells optimum growth factors, growing awareness of the benefits of cell culture-based vaccines, and rising focus on personalized medicine.
Within this market, biotechnology and pharmaceutical companies will remain the largest end user segment over the forecast period due to increasing research and development activities related to drug discovery and increasing production of vaccines.
North America will remain the largest region over the forecast period due to increasing research and development activities in biotechnology, rising healthcare investments by manufacturers, and presence of major players in the region.
Features of the Global Fetal Bovine Serum Market
Market Size Estimates: Global fetal bovine serum market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global fetal bovine serum market size by various segments, such as product, application, and end user in terms of value.Regional Analysis: Global fetal bovine serum market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global fetal bovine serum market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global fetal bovine serum market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global fetal bovine serum market by product (charcoal stripped, chromatographic, dialyzed FBS, exosome depleted, and stem cell), application (biopharmaceutical, cell culture, human & animal vaccine production, and others), end user (biotechnology & pharmaceutical company, academic institute, and research laboratory), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global fetal bovine serum market?
Q.5 What are the business risks and threats to the global fetal bovine serum market?
Q.6 What are emerging trends in this fetal bovine serum market and the reasons behind them?
Q.7 What are some changing demands of customers in this fetal bovine serum market?
Q.8 What are the new developments in this fetal bovine serum market? Which companies are leading these developments?
Q.9 Who are the major players in this fetal bovine serum market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this fetal bovine serum market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global fetal bovine serum market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell), Application (Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others), and End User (Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global fetal bovine serum market looks promising with opportunities in biopharmaceutical, cell culture, and human & animal vaccine production applications. The global fetal bovine serum market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are increasing research activities related to drug discovery and rising biopharmaceutical production.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global fetal bovine serum market report, please download the report brochure.
In this market, cell culture is the largest application of fetal bovine serum, whereas biotechnology & pharmaceutical company is the largest end user. Growth in various segments of the fetal bovine serum market are given below:
The study includes trends and forecast for the global fetal bovine serum market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Charcoal Stripped
Chromatographic
Dialyzed FBS (Fetal Bovine Serum)
Exosome Depleted
Stem Cell
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biopharmaceutical
Cell Culture
Human & Animal Vaccine Production
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic Institutes
Research Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the fetal bovine serum companies profiled in this report include Merck, GE Healthcare, Thermo Fisher Scientific, TCS Biosciences, HiMedia Laboratories, Atlanta Biologicals, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals, and Tissue Culture Biologicals.
Lucintel forecasts that cell culture will remain the largest application segment over the forecast period due to its increasing usage as a supplementary substance during cell culture protocols in order to give cultured cells optimum growth factors, growing awareness of the benefits of cell culture-based vaccines, and rising focus on personalized medicine.
Within this market, biotechnology and pharmaceutical companies will remain the largest end user segment over the forecast period due to increasing research and development activities related to drug discovery and increasing production of vaccines.
North America will remain the largest region over the forecast period due to increasing research and development activities in biotechnology, rising healthcare investments by manufacturers, and presence of major players in the region.
The future of the global fetal bovine serum market looks promising with opportunities in biopharmaceutical, cell culture, and human & animal vaccine production applications. The global fetal bovine serum market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are increasing research activities related to drug discovery and rising biopharmaceutical production.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global fetal bovine serum market report, please download the report brochure.
In this market, cell culture is the largest application of fetal bovine serum, whereas biotechnology & pharmaceutical company is the largest end user. Growth in various segments of the fetal bovine serum market are given below:
The study includes trends and forecast for the global fetal bovine serum market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Charcoal Stripped
Chromatographic
Dialyzed FBS (Fetal Bovine Serum)
Exosome Depleted
Stem Cell
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biopharmaceutical
Cell Culture
Human & Animal Vaccine Production
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic Institutes
Research Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the fetal bovine serum companies profiled in this report include Merck, GE Healthcare, Thermo Fisher Scientific, TCS Biosciences, HiMedia Laboratories, Atlanta Biologicals, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals, and Tissue Culture Biologicals.
Lucintel forecasts that cell culture will remain the largest application segment over the forecast period due to its increasing usage as a supplementary substance during cell culture protocols in order to give cultured cells optimum growth factors, growing awareness of the benefits of cell culture-based vaccines, and rising focus on personalized medicine.
Within this market, biotechnology and pharmaceutical companies will remain the largest end user segment over the forecast period due to increasing research and development activities related to drug discovery and increasing production of vaccines.
North America will remain the largest region over the forecast period due to increasing research and development activities in biotechnology, rising healthcare investments by manufacturers, and presence of major players in the region.
Features of the Global Fetal Bovine Serum Market
Market Size Estimates: Global fetal bovine serum market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global fetal bovine serum market size by various segments, such as product, application, and end user in terms of value.Regional Analysis: Global fetal bovine serum market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global fetal bovine serum market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global fetal bovine serum market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global fetal bovine serum market by product (charcoal stripped, chromatographic, dialyzed FBS, exosome depleted, and stem cell), application (biopharmaceutical, cell culture, human & animal vaccine production, and others), end user (biotechnology & pharmaceutical company, academic institute, and research laboratory), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global fetal bovine serum market?
Q.5 What are the business risks and threats to the global fetal bovine serum market?
Q.6 What are emerging trends in this fetal bovine serum market and the reasons behind them?
Q.7 What are some changing demands of customers in this fetal bovine serum market?
Q.8 What are the new developments in this fetal bovine serum market? Which companies are leading these developments?
Q.9 Who are the major players in this fetal bovine serum market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this fetal bovine serum market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global fetal bovine serum market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell), Application (Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others), and End User (Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Fetal Bovine Serum Market Trends and Forecast
3.3: Global Fetal Bovine Serum Market by Product
3.3.1: Charcoal Stripped
3.3.2: Chromatographic
3.3.3: Dialyzed FBS (Fetal Bovine Serum)
3.3.4: Exosome Depleted
3.3.3: Stem Cell
3.4: Global Fetal Bovine Serum Market by Application
3.4.1: Biopharmaceutical
3.4.2: Cell Culture
3.4.3: Human & Animal Vaccine Production
3.4.4: Others
3.5: Global Fetal Bovine Serum Market by End User
3.5.1: Biotechnology & Pharmaceutical Company
3.5.2: Academic Institute
3.5.3: Research Laboratory
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Fetal Bovine Serum Market by Region
4.2: North American Fetal Bovine Serum Market
4.2.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.2.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.2.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.2.4: The United States Fetal Bovine Serum Market
4.2.5: The Canadian Fetal Bovine Serum Market
4.2.6: The Mexican Fetal Bovine Serum Market
4.3: European Fetal Bovine Serum Market
4.3.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.3.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.3.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.3.4: The Fetal Bovine Serum Market of United Kingdom
4.3.5: The German Fetal Bovine Serum Market
4.3.6: The French Fetal Bovine Serum Market
4.4: APAC Fetal Bovine Serum Market
4.4.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.4.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.4.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.4.4: The Chinese Fetal Bovine Serum Market
4.4.5: The Indian Fetal Bovine Serum Market
4.4.6: The Japanese Fetal Bovine Serum Market
4.5: ROW Fetal Bovine Serum Market
4.5.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.5.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.5.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.5.4: Brazilian Fetal Bovine Serum Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Fetal Bovine Serum Market by Product
7.1.2: Growth Opportunities for the Global Fetal Bovine Serum Market by Application
7.1.3: Growth Opportunities for the Global Fetal Bovine Serum Market by End User
7.1.4: Growth Opportunities for the Global Fetal Bovine Serum Market by Region
7.2: Emerging Trends in the Global Fetal Bovine Serum Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Fetal Bovine Serum Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fetal Bovine Serum Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: GE Healthcare
8.3: Therm Fisher Scientific Inc.
8.4: TCS Biosciences Ltd.
8.5: HiMedia Laboratories
8.6: Atlanta Biologicals, Inc.
8.7: PAN-Biotech
8.8: Rocky Mountain Biologicals
8.9: Bovogen Biologicals Pty Ltd.
8.10: Tissue Culture Biologicals
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Fetal Bovine Serum Market Trends and Forecast
3.3: Global Fetal Bovine Serum Market by Product
3.3.1: Charcoal Stripped
3.3.2: Chromatographic
3.3.3: Dialyzed FBS (Fetal Bovine Serum)
3.3.4: Exosome Depleted
3.3.3: Stem Cell
3.4: Global Fetal Bovine Serum Market by Application
3.4.1: Biopharmaceutical
3.4.2: Cell Culture
3.4.3: Human & Animal Vaccine Production
3.4.4: Others
3.5: Global Fetal Bovine Serum Market by End User
3.5.1: Biotechnology & Pharmaceutical Company
3.5.2: Academic Institute
3.5.3: Research Laboratory
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Fetal Bovine Serum Market by Region
4.2: North American Fetal Bovine Serum Market
4.2.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.2.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.2.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.2.4: The United States Fetal Bovine Serum Market
4.2.5: The Canadian Fetal Bovine Serum Market
4.2.6: The Mexican Fetal Bovine Serum Market
4.3: European Fetal Bovine Serum Market
4.3.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.3.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.3.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.3.4: The Fetal Bovine Serum Market of United Kingdom
4.3.5: The German Fetal Bovine Serum Market
4.3.6: The French Fetal Bovine Serum Market
4.4: APAC Fetal Bovine Serum Market
4.4.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.4.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.4.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.4.4: The Chinese Fetal Bovine Serum Market
4.4.5: The Indian Fetal Bovine Serum Market
4.4.6: The Japanese Fetal Bovine Serum Market
4.5: ROW Fetal Bovine Serum Market
4.5.1: Market by Product: Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, and Stem Cell
4.5.2: Market by Application: Biopharmaceutical, Cell Culture, Human & Animal Vaccine Production, and Others
4.5.3: Market by End User: Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory
4.5.4: Brazilian Fetal Bovine Serum Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Fetal Bovine Serum Market by Product
7.1.2: Growth Opportunities for the Global Fetal Bovine Serum Market by Application
7.1.3: Growth Opportunities for the Global Fetal Bovine Serum Market by End User
7.1.4: Growth Opportunities for the Global Fetal Bovine Serum Market by Region
7.2: Emerging Trends in the Global Fetal Bovine Serum Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Fetal Bovine Serum Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fetal Bovine Serum Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: GE Healthcare
8.3: Therm Fisher Scientific Inc.
8.4: TCS Biosciences Ltd.
8.5: HiMedia Laboratories
8.6: Atlanta Biologicals, Inc.
8.7: PAN-Biotech
8.8: Rocky Mountain Biologicals
8.9: Bovogen Biologicals Pty Ltd.
8.10: Tissue Culture Biologicals
